For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The closing price of Origin Materials Inc (NASDAQ: ORGN) was $0.25 for the day, down -9.21% from the previous closing price of $0.27. In other words, the price has decreased by -$9.21 from its previous closing price. On the day, 4.29 million shares were traded. ORGN stock price reached its highest trading level at $0.2849 during the session, while it also had its lowest trading level at $0.2406.
Ratios:
Our analysis of ORGN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.28 and its Current Ratio is at 6.33. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In the most recent recommendation for the company, BofA Securities on January 14, 2025, Downgraded its rating to Underperform and sets its target price to $1.50 from $2.50 previously.
On August 16, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $1.35 to $3.
Craig Hallum Downgraded its Buy to Hold on August 11, 2023, while the target price for the stock was maintained at $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 19 ’25 when Bissell John sold 45,000 shares for $0.27 per share. The transaction valued at 12,078 led to the insider holds 1,997,973 shares of the business.
JOHN BISSELL bought 45,000 shares of ORGN for $11,472 on Dec 19 ’25. On Dec 16 ’25, another insider, Lee Joshua C., who serves as the General Counsel of the company, sold 18,200 shares for $0.36 each. As a result, the insider received 6,572 and left with 670,884 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORGN now has a Market Capitalization of 37394476 and an Enterprise Value of -11272526. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.49 while its Price-to-Book (P/B) ratio in mrq is 0.13. Its current Enterprise Value per Revenue stands at -0.449 whereas that against EBITDA is 0.214.
Stock Price History:
The Beta on a monthly basis for ORGN is 0.97, which has changed by -0.7194245 over the last 52 weeks, in comparison to a change of 0.13153219 over the same period for the S&P500. Over the past 52 weeks, ORGN has reached a high of $1.36, while it has fallen to a 52-week low of $0.26. The 50-Day Moving Average of the stock is -51.68%, while the 200-Day Moving Average is calculated to be -57.61%.
Shares Statistics:
ORGN traded an average of 1.33M shares per day over the past three months and 2506760 shares per day over the past ten days. A total of 150.53M shares are outstanding, with a floating share count of 136.52M. Insiders hold about 9.68% of the company’s shares, while institutions hold 10.86% stake in the company. Shares short for ORGN as of 1764288000 were 3900857 with a Short Ratio of 2.94, compared to 1761868800 on 3189118. Therefore, it implies a Short% of Shares Outstanding of 3900857 and a Short% of Float of 2.6199998.
